Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant Chemotherapy.
Amandine CrombéSophie CousinMariella Spalato CerusoFrançois Le LoarerMaud ToulmondeAudrey MichotMichèle KindEberhard StoeckleAntoine ItalianoPublished in: JCO clinical cancer informatics (2021)
Histologic response to NAC improves the prediction of MFS in patients with soft tissue sarcoma and represents a possible end point in future studies exploring innovative regimens in the neoadjuvant setting.